Codeship: Financing growth: Case study and Teaching note

A Work Project, presented as part of the requirements for the Award of a Masters Degree in Management from the NOVA – School of Business and Economics

Proyecto del curso puente virtual “biofarmacia y farmacocinetica” para alumnos master procedentes de otros grados distintos al de farmacia

El Master en Investigación, Desarrollo y Control de Medicamentos del actual Programa Oficial de Postgrado (POP) en Farmacia, y dentro del nuevo marco del Espacio Europeo de Educación superior, viene siendo impartido en la Facultad de Farmacia de la Universidad de Barcelona. El Master objeto de estudio, “Investigación, Desarrollo y Control de Medicamentos”, tiene un carácter interdisciplinar implicando la participación en la docencia de ocho Departamentos de la Universidad de Barcelona

BIOrienta2: orientación a futuros farmacéuticos. La Investigación en biomedicina como carrera profesional

El Grado de Farmacia ofrece una formación idónea para personas que enfoquen su carrera profesional como investigadores en el área de Biomedicina. Ninguna otra formación de Pregrado aúna conocimientos tan amplios en Microbiología, Parasitología, Química, Biología Molecular y Biotecnología así como en aspectos relacionados con el mecanismo de acción de fármacos y con alteracions fisio/patológicas a nivel molecular. Por ello, nos hemos planteado realizar un Plan de Acción Tutorial enfocado a formar alumnos desde sus etapas iniciales en la investigación en Biomedicina: elección de su trayectoria curricular, requisitos para realizar una carrera científica y oportunidades de formación en esta área

Views of pharmacy graduates and pharmacist tutors on evidence-based practice in relation to over-the-counter consultations: a qualitative study

RATIONALE, AIMS AND OBJECTIVES: Health care services offered to the public should be based on the best available evidence. We aimed to explore pharmacy tutors' and trainees' views on the importance of evidence when making decisions about over-the-counter (OTC) medicines and also to investigate whether the tutor influenced the trainee in practice.

METHODS: Following ethical approval and piloting, semi-structured interviews were conducted with pharmacy graduates (trainees) and pharmacist tutors. Transcribed interview data were entered into the NVivo software package (version 10), coded and analysed via thematic analysis.

RESULTS: Twelve trainees (five males, seven females) and 11 tutors (five males, six females) participated. Main themes that emerged were (in)consistency and contradiction, confidence, acculturation, and continuation and perpetuation. Despite having an awareness of the importance and potential benefits, an evidence-based approach did not seem to be routinely or consistently implemented in practice. Confidence in products was largely derived from personal use and patient feedback. A lack of discussion about evidence was justified on the basis of not wanting to lessen patient confidence in requested product(s) or possibly negating the placebo effect. Trainees became acculturated to 'real-life' practice; university teaching and evidence was deemed less relevant than meeting customer expectations. The tutor's actions were mirrored by their trainee resulting in continuation and perpetuation of the same professional attitudes and behaviours.

CONCLUSIONS: Evidence appeared to have limited influence on OTC decision making. The tutor played a key role in the trainee's professional development. More work could be performed to investigate how evidence can be regarded as relevant and something that is consistently implemented in practice.